How big is Omega Therapeutics, Inc.?

Jun 22 2025 06:15 PM IST
share
Share Via
As of Jun 18, Omega Therapeutics, Inc. has a market capitalization of 1.72 million, with net sales of 8.09 million and a net profit of -73.08 million over the last four quarters. Shareholder's funds total 58.02 million, and total assets are valued at 204.37 million.
As of Jun 18, Omega Therapeutics, Inc. has a market capitalization of 1.72 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 8.09 million, while the sum of net profit for the same period is -73.08 million.

As of Dec 23, the shareholder's funds amount to 58.02 million, and the total assets are valued at 204.37 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Omega Therapeutics, Inc. technically bullish or bearish?
Sep 20 2025 08:08 PM IST
share
Share Via
Is Omega Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:20 AM IST
share
Share Via
Is Omega Therapeutics, Inc. technically bullish or bearish?
Jun 25 2025 09:05 AM IST
share
Share Via
What does Omega Therapeutics, Inc. do?
Jun 22 2025 07:03 PM IST
share
Share Via